select a format

Single User License
USD 250 INR 16145
Site License
USD 500 INR 32290
Corporate User License
USD 750 INR 48435

Alternatively

Request a quote
Request a Customized research
Request for Sample Report





Recent Viewed Reports


Why Ken Reasearch?


Testimonials

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ... "Mohit Mittal, Consultant, KPMG Advisory Services"

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies.... "Mustafa Masood, Financial Analyst , Coldwell Banker Riyadh"

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"

The Report was very interesting and useful for me... "Marketing Manager, Western Union Business Solutions"


Washington University School of Medicine-Pharmaceuticals & Healthcare-Deals and Alliances Profile

Washington University School of Medicine-Pharmaceuticals & Healthcare-Deals and Alliances Profile


  • Products Id :- GDPH43602D
  • |
  • Pages: 34
  • |
  • May 2017
  • |
  • |
  Request for Sample Report

Executive Summary

Summary

Washington University School of Medicine (WUSTL), a subsidiary of University of Washington is a medical university that offers patient care, research, education services and neurology clinical trials. The university provides patient care services such as clinical, find a doctor, referring physicians and others. Its research program comprise post doctoral research opportunities, research labs, knight ADRC, hope center, MS center, infantile spasms, regional, synaptic, and others. The university conducts neurology clinical trials such as headaches, multiple sclerosis and stroke, brain, spinal cord and nervous system, behavior and performance unit, aging, and sleep disorders, among others. It operates through four campus located in St. Louis, the US. Washington University is headquartered in St. Louis, Missouri, the US.

Washington University School of Medicine-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

Business Description-A brief description of the company's operations.

Key Employees-A list of the key executives of the company.

Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

Key Competitors-A list of the key competitors of the company.

Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
ankur [@] kenresearch.com
+91-9015378249
www.kenresearch.com

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 4

Washington University School of Medicine, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5

Washington University School of Medicine, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6

Washington University School of Medicine, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7

Washington University School of Medicine, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8

Washington University School of Medicine, Medical Devices Deals, 2011 to YTD 2017 9

Washington University School of Medicine, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10

Washington University School of Medicine, Pharmaceuticals & Healthcare, Deal Details 11

Partnerships 11

C2N Diagnostics Expands Licensing Agreement with Washington University School of Medicine 11

LEO Pharma Enters into Agreement with Washington University School of Medicine 11

Licensing Agreements 12

Denali Therapeutics Enters into Licensing Agreement with Washington University School of Medicine 12

Washington University School of Medicine-Key Competitors 14

Key Employees 15

Locations And Subsidiaries 16

Head Office 16

Other Locations & Subsidiaries 16

Recent Developments 17

Government and Public Interest 17

Apr 19, 2017: Antibody helps detect protein implicated in Alzheimer's, other diseases 17

Dec 19, 2016: Landmark Alzheimer's prevention trial to evaluate third drug 19

Oct 26, 2016: Study Questions Benefits of Long-Term Home Oxygen Therapy for COPD Patients with Moderately Low Blood Oxygen Levels 21

Oct 18, 2016: Gates Foundation Awards $1.1 Million Grant for MediBeacon Collaboration with Washington University 23

Sep 23, 2016: Researchers Take a New Step Towards Non-Antibiotic Bladder Infection Therapies 24

Sep 21, 2016: New immunotherapy for leukemia shows promise in small clinical trial 26

Jul 19, 2016: Potential new target identified for treating itch 28

Jul 04, 2016: Immune-based therapy in mice shows promise against pancreatic cancer 29

May 10, 2016: Stem cells from diabetic patients coaxed to become insulin-secreting cells 30

Feb 11, 2016: Venter Institute, International Team of Researchers Publish Paper Outlining Key Genes in Toxoplasma gondii Strains that Contribute to Virulence 31

Feb 03, 2016: Receptors inside nerve cells may be a key to controlling pain 32

Product News 33

Jul 05, 2016: Potential drug target identified for deadly brain cancer 33

Appendix 34

Methodology 34

About GlobalData 34

Contact Us 34

Disclaimer 34

List of Figures

Washington University School of Medicine, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1

Washington University School of Medicine, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1

Washington University School of Medicine, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 1

Washington University School of Medicine, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 1

Washington University School of Medicine, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5

Washington University School of Medicine, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6

Washington University School of Medicine, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7

Washington University School of Medicine, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8

Washington University School of Medicine, Medical Devices Deals, 2011 to YTD 2017 9

List of Tables

Washington University School of Medicine, Pharmaceuticals & Healthcare, Key Facts 1

Washington University School of Medicine, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5

Washington University School of Medicine, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6

Washington University School of Medicine, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7

Washington University School of Medicine, Deals By Therapy Area, 2011 to YTD 2017 8

Washington University School of Medicine, Medical Devices Deals, 2011 to YTD 2017 9

Washington University School of Medicine, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10

C2N Diagnostics Expands Licensing Agreement with Washington University School of Medicine 11

LEO Pharma Enters into Agreement with Washington University School of Medicine 11

Denali Therapeutics Enters into Licensing Agreement with Washington University School of Medicine 12

Washington University School of Medicine, Key Competitors 14

Washington University School of Medicine, Key Employees 15

Washington University School of Medicine, Subsidiaries 16

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Washington University School of Medicine, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.


Ken Research Pvt. Ltd. 27A, Tower B-2, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India
+91 1244230204

download

Company Brochure

Engage with Us

query [@] kenresearch.com